- Telehealth Visits
- Insurance plan information
Emma Lutz, NP
Neurology • Headache Medicine- Telehealth Visits
- Insurance plan information
Headache Center Mount Zion
Emma Lutz, NP
Neurology • Headache MedicineHeadache Center Mount Zion
- Telehealth Visits
- Insurance plan information
On this page
About me
Emma Louise Lutz is a nurse practitioner who cares for patients with a broad range of headache disorders. She collaborates with doctors and other health professionals to ensure the best possible treatment plans for her patients.
In research, Lutz has interests in pain psychology and holistic approaches to patient care.
Lutz earned her master's degree in nursing at UCSF.
Education & training
Board certification
- Family Nurse Practitioner, American Academy of Nurse Practitioners
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%224583%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224583%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.